How Can Patients and Clinicians Make Informed Decisions About Otoprotective Agents?
Patients undergoing chemotherapy should discuss the potential risks of ototoxicity with their healthcare providers. Clinicians can provide information on the latest research and available options for otoprotection. In some cases, audiological monitoring and early intervention with otoprotective agents may be recommended. Participation in clinical trials may also be an option for patients interested in accessing new therapies under investigation.
